TSS
DFTX

Two Sigma Securities’s Definium Therapeutics DFTX Stock Holding History

Two Sigma Securities’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,099
Closed -$53K – 3043
2022
Q4 		$53K Buy
+24,099
New +$66.9K ﹤0.01% 2152
2022
Q3 		– Sell
-709
Closed -$7K – 2908
2022
Q2 		$7K Sell
709
-542
-43% -$6.86K ﹤0.01% 2089
2022
Q1 		$21K Sell
1,251
-1,172
-48% -$20.3K ﹤0.01% 1972
2021
Q4 		$50K Buy
+2,423
New +$77.3K ﹤0.01% 1276

Other funds holding DFTX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Two Sigma Securities's DFTX Position: Q1 2023 in Review

Two Sigma Securities sold out of Definium Therapeutics (DFTX) in Q1 2023, closing a stake of 24,099 shares — an estimated $53K sold.

Two Sigma Securities first reported a position in DFTX in Q4 2021 and held it in 4 quarters. The position peaked at $53K in Q4 2022. 88 funds tracked by Wall St. Rank hold DFTX as of Q1 2023.

  • Two Sigma Securities reported no remaining Definium Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 24,099 Definium Therapeutics shares in Q1 2023, an estimated $53K.
  • Two Sigma Securities first reported a position in Definium Therapeutics in Q4 2021 and held it in 4 quarters.
  • Two Sigma Securities's Definium Therapeutics position peaked at $53K in Q4 2022.
  • 88 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.